The global electrocompetent cells market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for high-quality recombinant proteins and increasing demand for toxic/unstable DNA cloning.
Cloned competent cells are the most commonly used type of electrocompetent cells in laboratories across the globe. These cells are used in various applications such as subcloning and routine cloning, phage display library construction, toxic/unstable DNA cloning, high-throughput cloning, protein expression, mutagenesis and single stranded DNA production. The cloned competent cell type accounted for over 50% of the total revenue generated by this market in 2017.
The application segment contributed over 60% of the total revenue generated by this market in 2017 due to its wide usage across various industries such as biotechnology & pharmaceuticals and research institutes & universities among others. North America was one of the leading regions with a share of over 40% in 2017 due to its large number of research institutes & universities that use these cells extensively for their research activities.
- The increasing demand for biopharmaceuticals and the need to produce them in large quantities is driving the growth of electrocompetent cells market.
- The increasing number of research and development activities in the field of biotechnology is also driving the growth of electrocompetent cells market.
- The growing awareness about electrocompetent cells among researchers, scientists, and pharmaceutical companies is also a major factor driving the growth of this market.
- The increasing number of mergers and acquisitions in this industry is also a major factor contributing to its growth.
- Increasing government funding for research activities related to electrocompetent cells are expected to fuel its demand over the forecast period.
Industry Growth Insights published a new data on “Electrocompetent Cells Market”. The research report is titled “Electrocompetent Cells Market research by Types (Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells), By Applications (Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)), By Players/Companies Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Electrocompetent Cells Market Research Report
By Type
Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells
By Application
Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)
By Companies
Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Electrocompetent Cells Market Report Segments:
The global Electrocompetent Cells market is segmented on the basis of:
Types
Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
Highlights of The Electrocompetent Cells Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cloned Competent Cells
- Agrobacterium tumefaciens Competent Cells
- Expression Competent Cells
- By Application:
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable Dna Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded Dna Production
- Bacmid creation
- Cre-lox recombination (PIR1/PIR2)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Electrocompetent Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Electrocompetent cells are cells that can generate an electric current.
Some of the major companies in the electrocompetent cells market are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics.
The electrocompetent cells market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Electrocompetent Cells Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Electrocompetent Cells Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Electrocompetent Cells Market - Supply Chain
4.5. Global Electrocompetent Cells Market Forecast
4.5.1. Electrocompetent Cells Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Electrocompetent Cells Market Size (000 Units) and Y-o-Y Growth
4.5.3. Electrocompetent Cells Market Absolute $ Opportunity
5. Global Electrocompetent Cells Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Electrocompetent Cells Market Size and Volume Forecast by Type
5.3.1. Cloned Competent Cells
5.3.2. Agrobacterium tumefaciens Competent Cells
5.3.3. Expression Competent Cells
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Electrocompetent Cells Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Electrocompetent Cells Market Size and Volume Forecast by Application
6.3.1. Subcloning & Routine Cloning
6.3.2. Phage Display Library Construction
6.3.3. Toxic/Unstable Dna Cloning
6.3.4. High-Throughput Cloning
6.3.5. Protein Expression
6.3.6. Mutagenesis
6.3.7. Single-Stranded Dna Production
6.3.8. Bacmid creation
6.3.9. Cre-lox recombination (PIR1/PIR2)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Electrocompetent Cells Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Electrocompetent Cells Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Electrocompetent Cells Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Electrocompetent Cells Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Electrocompetent Cells Demand Share Forecast, 2019-2026
9. North America Electrocompetent Cells Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Electrocompetent Cells Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Electrocompetent Cells Market Size and Volume Forecast by Application
9.4.1. Subcloning & Routine Cloning
9.4.2. Phage Display Library Construction
9.4.3. Toxic/Unstable Dna Cloning
9.4.4. High-Throughput Cloning
9.4.5. Protein Expression
9.4.6. Mutagenesis
9.4.7. Single-Stranded Dna Production
9.4.8. Bacmid creation
9.4.9. Cre-lox recombination (PIR1/PIR2)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Electrocompetent Cells Market Size and Volume Forecast by Type
9.7.1. Cloned Competent Cells
9.7.2. Agrobacterium tumefaciens Competent Cells
9.7.3. Expression Competent Cells
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Electrocompetent Cells Demand Share Forecast, 2019-2026
10. Latin America Electrocompetent Cells Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Electrocompetent Cells Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Electrocompetent Cells Market Size and Volume Forecast by Application
10.4.1. Subcloning & Routine Cloning
10.4.2. Phage Display Library Construction
10.4.3. Toxic/Unstable Dna Cloning
10.4.4. High-Throughput Cloning
10.4.5. Protein Expression
10.4.6. Mutagenesis
10.4.7. Single-Stranded Dna Production
10.4.8. Bacmid creation
10.4.9. Cre-lox recombination (PIR1/PIR2)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Electrocompetent Cells Market Size and Volume Forecast by Type
10.7.1. Cloned Competent Cells
10.7.2. Agrobacterium tumefaciens Competent Cells
10.7.3. Expression Competent Cells
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Electrocompetent Cells Demand Share Forecast, 2019-2026
11. Europe Electrocompetent Cells Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Electrocompetent Cells Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Electrocompetent Cells Market Size and Volume Forecast by Application
11.4.1. Subcloning & Routine Cloning
11.4.2. Phage Display Library Construction
11.4.3. Toxic/Unstable Dna Cloning
11.4.4. High-Throughput Cloning
11.4.5. Protein Expression
11.4.6. Mutagenesis
11.4.7. Single-Stranded Dna Production
11.4.8. Bacmid creation
11.4.9. Cre-lox recombination (PIR1/PIR2)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7 Europe Electrocompetent Cells Market Size and Volume Forecast by Type
11.7.1. Cloned Competent Cells
11.7.2. Agrobacterium tumefaciens Competent Cells
11.7.3. Expression Competent Cells
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Electrocompetent Cells Demand Share, 2019-2026
12. Asia Pacific Electrocompetent Cells Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Electrocompetent Cells Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Electrocompetent Cells Market Size and Volume Forecast by Application
12.4.1. Subcloning & Routine Cloning
12.4.2. Phage Display Library Construction
12.4.3. Toxic/Unstable Dna Cloning
12.4.4. High-Throughput Cloning
12.4.5. Protein Expression
12.4.6. Mutagenesis
12.4.7. Single-Stranded Dna Production
12.4.8. Bacmid creation
12.4.9. Cre-lox recombination (PIR1/PIR2)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Electrocompetent Cells Market Size and Volume Forecast by Type
12.7.1. Cloned Competent Cells
12.7.2. Agrobacterium tumefaciens Competent Cells
12.7.3. Expression Competent Cells
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Electrocompetent Cells Demand Share, 2019-2026
13. Middle East & Africa Electrocompetent Cells Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Electrocompetent Cells Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Electrocompetent Cells Market Size and Volume Forecast by Application
13.4.1. Subcloning & Routine Cloning
13.4.2. Phage Display Library Construction
13.4.3. Toxic/Unstable Dna Cloning
13.4.4. High-Throughput Cloning
13.4.5. Protein Expression
13.4.6. Mutagenesis
13.4.7. Single-Stranded Dna Production
13.4.8. Bacmid creation
13.4.9. Cre-lox recombination (PIR1/PIR2)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Electrocompetent Cells Market Size and Volume Forecast by Type
13.7.1. Cloned Competent Cells
13.7.2. Agrobacterium tumefaciens Competent Cells
13.7.3. Expression Competent Cells
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Electrocompetent Cells Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Electrocompetent Cells Market: Market Share Analysis
14.2. Electrocompetent Cells Distributors and Customers
14.3. Electrocompetent Cells Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck KGaA
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Takara Bio
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Promega Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beijing TransGen Biotech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GeneScript Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Yeastern Biotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. New England Biolabs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. QIAGEN N.V.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. OriGene Technologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Lucigen
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Zymo Research
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Bio-Rad Laboratories
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Bioline
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Delphi Genetics
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. IBA GmBH
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Cell Applications
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. BioDynamics Laboratory
&nb
